Announcement Summary

Entity name

RECCE PHARMACEUTICALS LTD

Announcement Type

New announcement

Date of this announcement

Friday September 29, 2023

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Total number of +securities to be quoted

ASX +securitycode	Security description	Number of +securities tobe quoted	Issue date
RCE	ORDINARY FULLY PAID	6,171,048	29/09/2023

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of entity

RECCE PHARMACEUTICALS LTD

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type ACN

Registration number 124849065

1.3 ASX issuer code RCE

1.4 The announcement is

New announcement

1.5 Date of this announcement

29/9/2023

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Previous Appendix 3B details:

Announcement Date andTime	Announcement Title	Selected Appendix 3B to submit quotationrequest
11-Sep-2023 09:52	New - Proposed issue of securities -RCE	A standard +pro rata issue (non-renounceable)

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

Yes

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

Subject to shareholder approval being obtained at the Company's Annual General Meeting to be held in November, placing approximately 250k shares from the Shortfall to Directors of the Company and the placement of the remaining Shortfall under the Entitlement Offer within 3 months of the Closing Date.

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Corporate Action Component Detail

ASX +security code and description

RCE : ORDINARY FULLY PAID

Issue date

29/9/2023

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

Number of +securities held	Number of holders	Total percentage of +securities heldFor example, to enter a value of 50%please input as 50.00
1 - 1,000		%
1,001 - 5,000		%
5,001 - 10,000		%
10,001 - 100,000		%
100,001 and over		%

Issue details

Number of +securities to be quoted

6,171,048

Issue currency

Issue price or consideration per +security

AUD - Australian Dollar

AUD 0.44000000

Any other information the entity wishes to provide about the +securities to be quoted

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

ASX +security code and description	Total number of+securities on issue
RCE : ORDINARY FULLY PAID	203,003,742

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

ASX +security code and description	Total number of+securities on issue
RCEAH : PERFORMANCE SHARES	8,754,423
RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56	435,000
RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	1,331,870
RCEAV : OPTION EXPIRING 30-SEP-2023 EX $1.56	3,750,000
RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56	8,415,000

AI assistant